GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CuraScientific Corp (OTCPK:CSTF) » Definitions » Total Stockholders Equity

CuraScientific (CuraScientific) Total Stockholders Equity : $-24.78 Mil (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is CuraScientific Total Stockholders Equity?

CuraScientific's Total Stockholders Equity for the quarter that ended in Sep. 2023 was $-24.78 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. CuraScientific's Book Value per Share for the quarter that ended in Sep. 2023 was $-0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. CuraScientific's Debt-to-Equity for the quarter that ended in Sep. 2023 was -0.03.


CuraScientific Total Stockholders Equity Historical Data

The historical data trend for CuraScientific's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CuraScientific Total Stockholders Equity Chart

CuraScientific Annual Data
Trend Dec20 Dec21 Dec22
Total Stockholders Equity
-196.70 -69.39 -69.51

CuraScientific Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.62 -69.51 -70.01 -25.89 -24.78

CuraScientific  (OTCPK:CSTF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

CuraScientific's Book Value per Share for the quarter that ended in Sep. 2023 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

CuraScientific's Debt-to-Equity for the quarter that ended in Sep. 2023 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CuraScientific Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of CuraScientific's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


CuraScientific (CuraScientific) Business Description

Traded in Other Exchanges
N/A
Address
51544 Cesar Chavez Street, Suite No. 1J, Coachella, CA, USA, 92236
CuraScientific Corp manufactures commercial chemicals with a variety of commercial sterilization applications for agriculture, warehousing, hospitality, and medical facilities. The company's product, DiOx+, is a disinfectant sterilizer that kills harmful pathogens without exposing people or the environment to dangerous toxins.
Executives
Paul Quentin Goyette director 2205 LOCH WAY, EL DORADO HILLS CA 95762
William Joseph Reed director, officer: Chief Executive Officer 333 N UNIVERSITY AVE., #33, REDLANDS CA 92374
Johann Loewen director C/O METHES ENERGIES INTERNATIONAL LTD, 3651 LINDELL ROAD, SUITE D-272, LAS VEGAS NV 89103
Edouard Maurice Beaudette director 13480 N BLOOMFIELD ROAD, NEVADA CITY CA 95959
Justin Michael Gonzalez director, officer: Chief Executive Officer 15723 LAKE VERA PURDON RD., NEVADA CITY CA 95959
Eric Jason Watson director, officer: Chief Operating Officer 19553 BOWERS DRIVE, TOPANGA CA 90290

CuraScientific (CuraScientific) Headlines

From GuruFocus

Introducing Leaf of Faith

By Marketwired Marketwired 03-26-2019